Lee E. Limbird Professor of Pharmacology
P. Jeffrey Conn, Ph.D.
P. Jeffrey Conn, Ph.D.
Director of the Vanderbilt Center for Neuroscience Drug Discovery
Scientific Council Member (Joined 2014)
2004 Distinguished Investigator Grant
1998 Independent Investigator Grant
Dr. Conn is the Lee E. Limbird Professor of Pharmacology at Vanderbilt University and Director of the Vanderbilt Center for Neuroscience Drug Discovery. He received the Ph.D. degree from Vanderbilt in 1986 and pursued postdoctoral studies at Yale University before joining the faculty at Emory University in 1988. Dr. Conn served as head of the Department of Neuroscience at Merck and Company (West Point, PA) from 2000 – 2003 then moved to Vanderbilt University as the founding director of the Canter for Neuroscience Drug Discovery, where he has advanced multiple drug candidates into development for treatment of brain disorders. Dr. Conn served as Editor in Chief of Molecular Pharmacology, on editorial boards of multiple other journals, and Scientific Advisory Boards of multiple foundations and companies. He has received numerous awards for his translational research.
Dr. Conn’s research is focused on development of novel therapies for schizophrenia, depression, and other brain disorders.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.